Post-Budget Summit
2025 AI Health Summit
This event will bring together leaders from the pharmaceutical industry, health and the broader life sciences sector, patient organisations, healthcare professionals, and technology innovators to explore how AI is transforming and will transform access to healthcare.
10 November 2025
Sydney, Australia
The Ivy Ballroom
The half-day summit will discuss the implications of the Labor federal government's first Budget and the progress of other policy initiatives, including the National Medicines Policy and health technology assessment reviews.
About The Event.
Discussions will include emerging AI-driven technologies, policy considerations and opportunities, institutional challenges, and strategies to foster patient-centric innovation.
Join us as we examine how AI can accelerate research, improve treatments, and empower patients—shaping a more effective and inclusive healthcare future.
Speakers include AI experts, healthcare leaders, as well as key influencers and decision-makers.
+200
8
Participants
Sessions
Speakers
More speakers will be confirmed in the coming days and weeks
Program
8:00 – 9:00 | Registration, Coffee & Networking
Welcome and opportunity to connect with delegates, speakers, and sponsors.
9:00 – 9:15 | Welcome & Opening Remarks
Paul Cross
Overview of the Summit’s purpose: the intersection of AI, health policy, and patient outcomes.
9:15 – 10:00 | Opening Keynote: The Future of AI in Global Health Systems
Dr Andree Bates, Founder & CEO, Eularis
AI in Pharma: Threat or Opportunity?
A provocative look at how AI is transforming decision-making, drug development, and patient access worldwide.
10:00 – 10:30 | Health consumer preferences and attitudes towards AI
Vinh Vo, Shaview Consulting and Monash University
10:30 – 11:00 | Plenary Panel – Balancing Innovation and Accountability in AI-Driven Decisions
Professor Robyn Ward AM, PBAC Chair, Deputy Vice-Chancellor (Research and Enterprise) and Senior Vice-President at Monash University
11:00 – 11:20 | Break
11:20 – 11:50 | Plenary Panel – Is the HTA Review considering the future use of AI?
Professor Andrew Wilson AO, Chair, HTA Review, Implementation Advisory Group
11:50 – 12:20 | Plenary insight
Karen Hood, Healthcare Executuve
12:20 - 1.00 | Corporate case study – Sanofi’s adoption of AI
Liz Selby, Country Lead and Head of Pharma, Sanofi
Luke Cornish, Health of Corporate Affairs, Sanofi
James Scott, Health of Medical - Pharma, Sanofi
1:00 – 1:50 | Break
1:50 – 2:30 | Fireside Conversation – The Global AI Race in Health Innovation
Bronwyn Le Grice, CEO, ANDHealth
Romain Bonjean, Co-CEO, RoseRx
Rebecca Wilson, Chair, Alcidion Group and Clever Culture Systems. Director, Vitura Health and Hansen Technologies
2:30 – 3:00 | Corporate case study – HCF’s adoption of AI
Tom Robinson, Head of Innovation, NCF Australia
3:00 – 3:20 | Break
3:20 - 3.50 | Corporate case study – Data Collaboration
Peter Cronin, Co-Founder, Prospection
Vishal Kapoor, Head of Japan and Analytics Lead, Prospection
3:50 - 4:30 | The wider opportunity of AI - is it real?
Gabi Mittas, Associate Vice President, Managing Director, Amgen, Australia and NZ
Dr Katherine Bassett, Director of Health Policy, Catholic Health Australia
Dr Kathryn Evans, General Manager, Argenx
4:30 - 4:45 | Closing remarks
Register.
Register for the 2025 BPD AI Health Summit